A previous study mentioned that metformin, an AMPK activator, can block melanoma from invasion and metastasis by suppressing the activities and expressions of gelatinases (MMP-2 and MMP-9) in an AMPK-p53-dependent manner [25]. Here, MMP2 is linked to melanoma.